$AEGR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aegerion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Aegerion Pharmaceuticals, Inc.. Get notifications about new insider transactions in Aegerion Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 01 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 0.00 | 4,361,291 | 0 | 0 | 4.4 M to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Plutzky Jorge MD | Director | Option Exercise | D | 25.99 | 31,182 | 810,420 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | ||
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 2.46 | 69,000 | 169,740 | 0 | ||
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 5.71 | 200,000 | 1,142,000 | 0 | ||
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.52 | 40,000 | 780,800 | 0 | ||
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.58 | 200,000 | 3,916,000 | 0 | ||
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 0.00 | 8,000 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 2.46 | 17,000 | 41,820 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 10.42 | 85,000 | 885,700 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 7,300 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 5,100 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 2,500 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 1,733 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 3,500 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 3,282 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.19 | 30,000 | 395,700 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 26.00 | 3,399 | 88,374 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 26.00 | 1,701 | 44,226 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 47.11 | 14,324 | 674,804 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 47.11 | 2,676 | 126,066 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 39.02 | 10,683 | 416,851 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 39.02 | 1,817 | 70,899 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.39 | 15,096 | 202,135 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.39 | 25,529 | 341,833 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Sell | D | 0.00 | 1,704 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Chan Barbara Y | VP, Chief Accountin ... | Option Exercise | D | 1.58 | 26,000 | 41,080 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 0.00 | 4,000 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 2.46 | 7,000 | 17,220 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 5.43 | 75,000 | 407,250 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 37.66 | 14,700 | 553,602 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Sell | D | 0.00 | 4,000 | 0 | 0 | 4 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 15.26 | 23,521 | 358,930 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Sell | D | 0.00 | 36,978 | 0 | 0 | 37 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 0.00 | 97,000 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 2.46 | 194,000 | 477,240 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 8.65 | 600,000 | 5,190,000 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Stern Donald K | Director | Option Exercise | D | 17.68 | 31,182 | 551,298 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 0.00 | 8,888 | 0 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 18.26 | 40,000 | 730,400 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 15.00 | 8,569 | 128,535 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.28 | 16,435 | 267,562 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Sell | D | 0.00 | 2,890 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 9.50 | 10,238 | 97,261 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Sell | D | 0.00 | 13,916 | 0 | 0 | 13.9 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | D | 0.00 | 521,350 | 0 | 0 | 521.4 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 19.25 | 19,927 | 383,595 | 0 | |
Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Sell | D | 0.00 | 29,890 | 0 | 0 | 29.9 K to 0 (-100.00 %) |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Option Exercise | M | 0.00 | 1,642 | 0 | 3,282 | |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Option Exercise | M | 0.00 | 867 | 0 | 1,733 | |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 1.78 | 532 | 947 | 1,704 | 2.2 K to 1.7 K (-23.79 %) |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Buy | M | 0.00 | 1,642 | 0 | 2,236 | 594 to 2.2 K (+276.43 %) |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Payment of Exercise | F | 3.55 | 273 | 969 | 594 | 867 to 594 (-31.49 %) |
Sep 20 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel | Buy | M | 0.00 | 867 | 0 | 867 | 0 to 867 |
Sep 14 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.75 | 75,000 | 131,250 | 4,361,291 | 4.3 M to 4.4 M (+1.75 %) |
Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 76,000 | 129,200 | 4,286,291 | 4.2 M to 4.3 M (+1.81 %) |
Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.70 | 100,000 | 169,600 | 4,210,291 | 4.1 M to 4.2 M (+2.43 %) |
Sep 12 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 1.60 | 100,000 | 159,500 | 4,110,291 | 4 M to 4.1 M (+2.49 %) |
Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,222 | 0 | 8,888 | |
Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 1.55 | 777 | 1,204 | 2,890 | 3.7 K to 2.9 K (-21.19 %) |
Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,222 | 0 | 3,667 | 1.4 K to 3.7 K (+153.77 %) |
Jul 05 2016 | AEGR | Aegerion Pharmaceu ... | Chan Barbara Y | VP, Chief Accountin ... | Option Exercise | A | 1.58 | 26,000 | 41,080 | 26,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | Acting General Coun ... | Option Exercise | A | 0.00 | 7,300 | 0 | 7,300 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | Acting General Coun ... | Option Exercise | A | 0.00 | 5,100 | 0 | 5,100 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 2.46 | 69,000 | 169,740 | 69,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | A | 2.46 | 17,000 | 41,820 | 17,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | A | 0.00 | 97,000 | 0 | 97,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | A | 2.46 | 194,000 | 477,240 | 194,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 0.00 | 13,000 | 0 | 13,000 | |
May 11 2016 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 2.46 | 26,000 | 63,960 | 26,000 | |
Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 4,976 | 37,320 | 0 | |
Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | E | 17.50 | 5,000 | 87,500 | 0 | |
Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Option Exercise | X | 7.50 | 24 | 180 | 0 | |
Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 497,600 | 3,732,000 | 4,010,291 | 3.5 M to 4 M (+14.17 %) |
Mar 21 2016 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | X | 7.50 | 2,400 | 18,000 | 3,512,691 | 3.5 M to 3.5 M (+0.07 %) |
Feb 17 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 5.71 | 200,000 | 1,142,000 | 200,000 | |
Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,223 | 0 | 11,110 | |
Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 6.78 | 778 | 5,275 | 1,445 | 2.2 K to 1.4 K (-35.00 %) |
Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,223 | 0 | 2,223 | 0 to 2.2 K |
Jan 11 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | A | 8.65 | 600,000 | 5,190,000 | 600,000 | |
Dec 03 2015 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | J | 0.00 | 64,014 | 0 | 521,350 | 585.4 K to 521.4 K (-10.94 %) |
Dec 03 2015 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | J | 0.00 | 1,855 | 0 | 585,364 | 587.2 K to 585.4 K (-0.32 %) |
Dec 02 2015 | AEGR | Aegerion Pharmaceu ... | Louis Roger | See Remarks | Option Exercise | A | 10.42 | 85,000 | 885,700 | 85,000 | |
Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.96 | 35,000 | 383,600 | 4,010,291 | 4 M to 4 M (+0.88 %) |
Nov 13 2015 | AEGR | Aegerion Pharmaceu ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 10.99 | 5,100 | 56,049 | 3,975,291 | 4 M to 4 M (+0.13 %) |
Oct 05 2015 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | A | 13.19 | 30,000 | 395,700 | 30,000 | |
Sep 18 2015 | AEGR | Aegerion Pharmaceu ... | Stern Donald K | Director | Option Exercise | A | 17.68 | 31,182 | 551,298 | 31,182 | |
Sep 18 2015 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | A | 0.00 | 4,924 | 0 | 4,924 | |
Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 0.00 | 13,333 | 0 | 13,333 | |
Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 18.26 | 40,000 | 730,400 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | Weger Mary | Chief Performance O ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | Andrews William T. | See Remarks | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | Cook Anne Marie | SVP, General Counse ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
Aug 04 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.58 | 200,000 | 3,916,000 | 200,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
May 07 2015 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
May 07 2015 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 23.61 | 13,000 | 306,930 | 13,000 | |
Apr 10 2015 | AEGR | Aegerion Pharmaceu ... | Plutzky Jorge MD | Director | Option Exercise | A | 25.99 | 31,182 | 810,420 | 31,182 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Weger Mary | Chief Performance O ... | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Weger Mary | Chief Performance O ... | Option Exercise | A | 26.00 | 27,000 | 702,000 | 27,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Andrews William T. | See Remarks | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Andrews William T. | See Remarks | Option Exercise | A | 26.00 | 27,000 | 702,000 | 27,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Fitzpatrick Mark J. | Chief Financial Off ... | Option Exercise | A | 26.00 | 40,000 | 1,040,000 | 40,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Option Exercise | A | 0.00 | 33,000 | 0 | 33,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Beer Marc D | Chief Executive Off ... | Option Exercise | A | 26.00 | 133,000 | 3,458,000 | 133,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 0.00 | 7,000 | 0 | 7,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Carter Martha J. | See Remarks | Option Exercise | A | 26.00 | 27,000 | 702,000 | 27,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Fraser Craig | Chief Operating Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Fraser Craig | Chief Operating Off ... | Option Exercise | A | 26.00 | 37,000 | 962,000 | 37,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Sumeray Mark | Chief Medical Offic ... | Option Exercise | A | 26.00 | 40,000 | 1,040,000 | 40,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Cook Anne Marie | SVP, General Counse ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Apr 03 2015 | AEGR | Aegerion Pharmaceu ... | Cook Anne Marie | SVP, General Counse ... | Option Exercise | A | 26.00 | 40,000 | 1,040,000 | 40,000 | |
Jan 05 2015 | AEGR | Aegerion Pharmaceu ... | Cook Anne Marie | SVP, General Counse ... | Option Exercise | A | 15.95 | 45,000 | 717,750 | 45,000 |